Light-Activated Tool Helps to Better Understand Diabetes Drugs

Light Activated Tools

 

May 07 2016

Sandra Henderson

Researchers at the University of Birmingham (UK) have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes. 

The study, published in Angewandte Chemie, provides insight into the signalling process of receptors in cells. The findings could lead to a new generation of anti-diabetic drugs that are activated by either blue or ultra-violet light. 

David Hodson, PhD, from Birmingham’s Institute of Metabolism and Systems Research, explains the new light-activated tool that could help optimize T2D drugs: “The GLP-1 receptor is involved in the maintenance of normal glucose levels and is presently targeted by a number of blockbuster T2D drugs,” the expert says. “However, the function of this receptor is poorly understood. In particular, drugs that bind a ‘hidden’ allosteric site may be safer and more specific alternatives to present therapies.” 

Hodson further notes that production of such drugs is at present hindered by the lack of information about how the allosteric site works. “Together with Dirk Trauner and Johannes Broichhagen at LMU Munich, we have designed a new drug, termed PhotoETP, whose conformation and binding can be controlled by light,” he reports. “This allows us to understand precisely the interactions that need to occur between a molecule and the allosteric site for full operation.” 

Researchers able to change conformation/activity of positive allosteric modulator using light  

The promising research breaks new ground in the realm of light-activated tools for optimizing drugs. “PhotoETP is termed a positive allosteric modulator,” says Hodson. “While these exist, no one has been able to change their conformation or activity using light. We have done this by incorporating an azobenzene photoresponsive element that undergoes isomerization following illumination.” 

The expert confirms that the innovation could, in fact, catalyze a new generation of drugs activated by blue or ultraviolet light. “We have already produced a range of light-activated anti-diabetics that target ion channels and G protein coupled receptors,” he says. “The aim of PhotoETP is to provide a tool that allows allosteric signalling at the GLP-1 receptor to be properly understood, with implications for the rationale design of drugs that will supersede the incretin-mimetics due to their improved safety and efficacy.” 

Photopharmacology evolves 
The findings could represent a photopharmacological stepping stone on the path to light-activated drugs of the future. “Light-activated antibiotics, chemotherapeutics and anti-diabetics have all been produced,” Hodson notes. “These studies are further evidence that, one day, photopharmacology — the targeting of drug activity in space and time — may become inherent to drug design and disease treatment.” 

In that endeavour, Hodson and his team are well underway toward realizing light-activated anti-diabetics. “We have begun to synthesize variants of PhotoETP that will provide further clues as to how the GLP-1 receptor works,” he reveals. “Moreover, we are performing proof-of-concept experiments to show that light-activated anti-diabetics can be safely used in vivo to control blood glucose levels.” 

Sandra Henderson is Research Editor, Novus Light Technologies Today.

 Photo: novuslight.com

Related Articles


Changing Scene

  • LEDVANCE Expands Ontario Presence with New Specification Agent

    LEDVANCE Expands Ontario Presence with New Specification Agent

    LEDVANCE is pleased to announce the appointment of Sterling Architectural Products Ltd. (Sterling Lights) as their new specification agent in Ontario. This partnership strengthens LEDVANCE’s presence in the region and reinforces their commitment to serving the professional lighting design and specification community with innovative, reliable lighting solutions. With decades of experience and a service-driven mindset,… Read More…

  • May 29, 2025 - Eureka Wins Three 2025 Red Dot Awards for Product Design

    Eureka Wins Three 2025 Red Dot Awards for Product Design

    Eureka is pleased to announce that its Velia, Cirra, and Junction luminaires have each received a 2025 Red Dot Design Award for Product Design. It is the 11th consecutive year that Eureka products have been honored with this prestigious award, which is a testament to the company’s consistency and relentless drive to design exceptional luminaires.… Read More…


Design

  • What is Human Centric Lighting: Benefits & Applications

    What is Human Centric Lighting: Benefits & Applications

    Human centric lighting (HCL) is a kind of illuminated way based on human physical and psychological needs. Its core goal is to imitate the changes in natural light to support the body’s circadian rhythm, improve visual comfort, and enhance mood. The key element of human centric lighting contains dynamic ​color temperature adjustment, adjustable brightness, spectrum… Read More…

  • Mac’s II Agencies: Case Study – Tesoro, Vancouver, BC

    Mac’s II Agencies: Case Study – Tesoro, Vancouver, BC

    At the crest of False Creek, Tesoro stands as a contemporary interpretation of classic luxury, offering 92 exclusive waterfront homes in the heart of Vancouver. Developed by Concert Properties, this 17-story residential tower embraces a distinctly modern character, harmonizing sleek design with timeless sophistication. The vision for Tesoro extended beyond its architectural presence—it was about… Read More…


New Products

  • Elevate Your Lighting with Magic Lite’s CCT Streamline Tape & Rotating Scene Control Panel

    Elevate Your Lighting with Magic Lite’s CCT Streamline Tape & Rotating Scene Control Panel

    Looking for the ultimate in flexibility and flawless aesthetics for your next lighting project? Meet the new CCT Streamline Tape and Rotating Scene Control Panel from Magic Lite—your solution for perfectly tunable, zero-pixelation illumination. Indoor and Outdoor options – both cuttable and re-connectable! Read More…

  • GVA Lighting: PIXEL GEN2 COLOR CHANGING

    GVA Lighting: PIXEL GEN2 COLOR CHANGING

    PIXEL GEN2 is the second generation of the direct-view PIXEL series, designed for dynamic color effects, low-resolution image displays, and media façades. Built on the award-winning COLOR-STREAM platform, it delivers 16X faster communication than DMX, ensuring ultra-smooth dimming and real-time responsiveness. With INFINITY technology, PIXEL GEN2 supports lighting circuits of up to 1,565 PIXELs, providing… Read More…